A new therapy is reportedly being tested for the treatment of a deadly lung cancer.
A new therapy is reportedly being tested for the treatment of squamous non-small cell lung cancer. As reported by UPI.com, researchers in the U.S. are testing a viral therapy called Reolysin on up to 55 cancer patients who meet the criteria in a clinical study for the treatment.
As noted in the report, the experimental treatment reportedly works with other therapies used to eradicate cancer cells, without destroying normal cells in patients. Dr. Alain Mita is quoted in the report as stating of the new study in a statement, “The study offers new hope for this group of patients with lung cancer.”
As noted in the report, enrollment for the trial has begun by Cancer Therapy & Research Center at the University of Texas Health Science Center at San Antonio researchers.